Alergologia Polska - Polish Journal of Allergology
eISSN: 2391-6052
ISSN: 2353-3854
Alergologia Polska - Polish Journal of Allergology
Bieżący numer Archiwum Artykuły zaakceptowane O czasopiśmie Suplementy Zeszyty specjalne Rada naukowa Bazy indeksacyjne Prenumerata Kontakt Zasady publikacji prac Opłaty publikacyjne Standardy etyczne i procedury
Panel Redakcyjny
Zgłaszanie i recenzowanie prac online
3/2025
vol. 12
 
Poleć ten artykuł:
Udostępnij:
streszczenie artykułu:
Artykuł oryginalny

Diagnosis of reported beta-lactam hypersensitivity in different diagnostic risk groups

Lesia Rozłucka
1
,
Joanna Glück
1
,
Paula Olszewska
1
,
Barbara Rymarczyk
1
,
Radosław Gawlik
1

  1. Department of Internal Medicine, Allergology and Clinical Immunology, Medical University of Silesia, Katowice, Poland
Alergologia Polska – Polish Journal of Allergology 2025; 12, 3: 163–171
Data publikacji online: 2025/08/20
Pełna treść artykułu Pobierz cytowanie
 
Metryki PlumX:


Introduction:
Beta-lactam (BL) antibiotics are one of the most common causes of drug hypersensitivity. Diagnosis of hypersensitivity to BL antibiotics includes: skin prick tests (SPT), intradermal tests (IDT), drug provocation tests (DPT) and allergen-specific IgE (sIgE) determination. Diagnostic methods of BL hypersensitivity remain the same for years.

Aim:
The aim of our study was to analyze the relevance of diagnostic methods in patients with reported BL allergy in different diagnostic risk groups.

Material and methods:
The database included a detailed medical history, laboratory test results and allergy work-up. 263 patients were included in the study. The low-risk group consisted of 88 (33.46%) patients, moderate of 129 (49.05%) patients and 46 (17.49%) patients were classified to the high diagnostic risk group.

Results:
Diagnostic risk groups of hypersensitivity to BL antibiotics do not differ in laboratory results, including a specific IgE level. In 23 (8.7%) patients, hypersensitivity to BL antibiotics was confirmed regardless of the risk group. Among the patients with positive skin tests (10/263, 3.8%) or provocation test (13/263, 4.9%), 6 (2.3%) patients were diagnosed with hypersensitivity to the BL ring, 2 (0.76%) with cross-sensitivity between aminopenicillin, and amino-cephalosporin, 3 (1.14%) were diagnosed with hypersensitivity to two BL antibiotics from different groups, 12 (4.5%) had confirmed hypersensitivity to the reported BL antibiotic, including 6 (2.3%) diagnosed with IgE-independent hypersensitivity to the reported BL antibiotic.

Conclusions:
Diagnostic risk groups of hypersensitivity to BL antibiotics do not differ in laboratory results. Skin tests are useful in diagnosing hypersensitivity to BL antibiotics, but DPT remain the gold standard.

POLECAMY
KONFERENCJE
Webinar Testowy


© 2026 Termedia Sp. z o.o.
Developed by Termedia.